Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/9/2025

Gabapentin and Diclofenac Interaction Guidelines

Introduction to Gabapentin and Diclofenac

  • The American Academy of Family Physicians notes that no clinically significant pharmacokinetic interaction exists between gabapentin and diclofenac, making this combination generally safe to use together when clinically indicated 1, 2
  • Gabapentin is not metabolized by the cytochrome P450 system and is primarily excreted unchanged through the kidneys, minimizing the risk of metabolic drug interactions with diclofenac 2, 3

Key Interaction Information

  • Diclofenac (Cataflam) is an NSAID that undergoes hepatic metabolism through the CYP system, but does not significantly affect gabapentin's pharmacokinetics 1
  • Unlike some anticonvulsants, gabapentin has minimal drug interaction potential 2, 3

Safety Considerations

  • Both medications can affect renal function, so combined use requires monitoring, especially in elderly patients 4, patients with pre-existing renal impairment 2, 3, and patients taking other nephrotoxic medications 1
  • The American Geriatrics Society recommends caution with NSAIDs like diclofenac in older adults due to increased risk of GI bleeding 1, renal impairment 3, and cardiovascular events 4

Special Populations

  • Gabapentin requires dose adjustment in elderly patients with reduced renal function 2, 5
  • Diclofenac can cause hepatic complications and should be used with caution in patients with liver disease 1
  • Gabapentin exposure increases in moderate hepatic impairment (2.3-fold) 3

Clinical Recommendations

  • Start with lower doses of both medications when using in combination, especially in elderly patients or those with renal impairment 2, 5
  • Consider gabapentin 100-300 mg daily initially with gradual titration 2
  • Use the lowest effective dose of diclofenac for the shortest duration 1
  • Assess renal function before initiating therapy and periodically during treatment 2, 3
  • Monitor for increased sedation, dizziness, or cognitive effects, especially when initiating therapy 2
  • Watch for signs of GI bleeding or cardiovascular effects from diclofenac 1
  • Advise patients about potential additive CNS effects and caution regarding driving or operating machinery 2, 4
  • Instruct patients to report unusual bleeding, edema, or changes in mental status 1, 2